Published in Nat Med on April 08, 2007
Urothelial signaling. Physiol Rev (2013) 2.56
Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol (2009) 2.52
A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion. Cell (2015) 2.24
Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol (2009) 2.19
Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med (2011) 2.16
A murine model of urinary tract infection. Nat Protoc (2009) 2.15
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother (2010) 2.05
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med (2013) 1.88
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A (2012) 1.84
Uroplakins in urothelial biology, function, and disease. Kidney Int (2009) 1.79
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun (2012) 1.64
Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci U S A (2009) 1.56
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One (2008) 1.54
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells. PLoS Pathog (2015) 1.47
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Urinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulence. Virulence (2011) 1.43
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med (2013) 1.38
TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A (2009) 1.38
A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol (2011) 1.26
Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun (2010) 1.19
Urinary tract infections in women: etiology and treatment options. Int J Gen Med (2011) 1.08
Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides. J Med Chem (2012) 1.05
Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol (2012) 1.02
How does the urothelium affect bladder function in health and disease? ICI-RS 2011. Neurourol Urodyn (2012) 1.02
Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A (2013) 1.02
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun (2010) 0.99
Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun (2012) 0.97
Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J Infect Dis (2014) 0.87
Aberrant community architecture and attenuated persistence of uropathogenic Escherichia coli in the absence of individual IHF subunits. PLoS One (2012) 0.87
The nature of immune responses to urinary tract infections. Nat Rev Immunol (2015) 0.86
New paradigms of urinary tract infections: Implications for patient management. Indian J Urol (2012) 0.86
Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli. J Cell Biol (2011) 0.86
Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS One (2010) 0.85
How to make it in the urinary tract: a tutorial by Escherichia coli. PLoS Pathog (2012) 0.85
High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents. PLoS One (2010) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect Immun (2012) 0.84
Characteristics of the phagocytic cup induced by uropathogenic Escherichia coli. J Histochem Cytochem (2008) 0.84
Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech (2013) 0.82
Temporally and spatially controllable gene expression and knockout in mouse urothelium. Am J Physiol Renal Physiol (2010) 0.82
Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity. MBio (2015) 0.82
UPEC hemolysin: more than just for making holes. Cell Host Microbe (2012) 0.81
Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium. PLoS One (2014) 0.81
Transurethral induction of mouse urinary tract infection. J Vis Exp (2010) 0.80
Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis. Nat Rev Nephrol (2015) 0.80
How the Innate Immune System Senses Trouble and Causes Trouble. Clin J Am Soc Nephrol (2014) 0.80
Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli. Am J Pathol (2014) 0.80
Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection. Microbiol Spectr (2015) 0.79
Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens (2016) 0.79
Flushing bacteria out of the bladder. Nat Med (2007) 0.79
Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells. Autophagy (2016) 0.79
Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. Microbiol Mol Biol Rev (2016) 0.78
Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5. Genome Announc (2015) 0.78
Ubiquitination of Innate Immune Regulator TRAF3 Orchestrates Expulsion of Intracellular Bacteria by Exocyst Complex. Immunity (2016) 0.78
Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med (2016) 0.77
Androgens Enhance Male Urinary Tract Infection Severity in a New Model. J Am Soc Nephrol (2015) 0.77
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol (2016) 0.77
Who's really in control: microbial regulation of protein trafficking in the epithelium. Am J Physiol Cell Physiol (2013) 0.76
Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP. Am J Respir Cell Mol Biol (2012) 0.76
Invasion of Host Cells and Tissues by Uropathogenic Bacteria. Microbiol Spectr (2016) 0.75
The multiple antibacterial activities of the bladder epithelium. Ann Transl Med (2017) 0.75
Innate Immune Responses to Bladder Infection. Microbiol Spectr (2016) 0.75
A Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium. Infect Immun (2017) 0.75
A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet (2012) 3.03
Topological structure analysis of the protein-protein interaction network in budding yeast. Nucleic Acids Res (2003) 2.90
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol (2003) 2.68
Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med (2008) 2.27
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell (2006) 1.92
Concern c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am J Respir Crit Care Med (2011) 1.91
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med (2011) 1.80
Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation. Respir Care (2012) 1.73
Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem (2004) 1.72
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. Proc Natl Acad Sci U S A (2007) 1.64
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Microbial entry through caveolae: variations on a theme. Cell Microbiol (2002) 1.44
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog (2007) 1.41
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A (2009) 1.38
The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta (2005) 1.23
Transforming academic health centers for an uncertain future. N Engl J Med (2013) 1.20
The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts. J Biol Chem (2005) 1.20
Innate immunity and its regulation by mast cells. J Immunol (2013) 1.19
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe (2009) 1.17
Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2. J Biol Chem (2004) 1.13
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett (2004) 1.10
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine (2009) 1.09
The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol (2002) 1.06
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol (2003) 1.04
Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J Biol Chem (2009) 1.02
Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata. G3 (Bethesda) (2012) 1.02
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med (2009) 0.99
Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One (2010) 0.99
Respiratory failure early after lung transplantation: now that we know the extent of the problem, what are the solutions? Chest (2003) 0.94
Bacterial penetration of the mucosal barrier by targeting lipid rafts. J Investig Med (2005) 0.92
Intestinal mast cells mediate gut injury and systemic inflammation in a rat model of deep hypothermic circulatory arrest. Crit Care Med (2013) 0.91
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest (2011) 0.91
Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol (2013) 0.91
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits. PLoS One (2011) 0.91
Lens epithelial cell death and reduction of anti-apoptotic protein Bcl-2 in human anterior polar cataracts. Mol Vis (2002) 0.90
The mast cell in innate and adaptive immunity. Adv Exp Med Biol (2011) 0.89
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis. J Immunol (2006) 0.89
Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice. Int Immunopharmacol (2011) 0.87
Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci (2011) 0.86
TGF-beta-induced apoptosis and reduction of Bcl-2 in human lens epithelial cells in vitro. Curr Eye Res (2002) 0.85
Involvement of dynamin-2 in formation of discoid vesicles in urinary bladder umbrella cells. Cell Tissue Res (2009) 0.85
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death. Am J Respir Crit Care Med (2013) 0.85
Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol (2011) 0.85
Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation. Am J Physiol Lung Cell Mol Physiol (2005) 0.85
New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol (2009) 0.83
The expanding roles of caveolin proteins in microbial pathogenesis. Commun Integr Biol (2009) 0.83
Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech (2013) 0.82
New roles for mast cells in pathogen defense and allergic disease. Discov Med (2010) 0.81
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Vaccine (2013) 0.81
Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5. Genome Announc (2015) 0.78
In vivo models for studying mast cell-dependent responses to bacterial infection. Methods Mol Biol (2006) 0.78
Cases from the Osler Medical Service at Johns Hopkins University. Scedosporium apiospermum mycetoma of the lung. Am J Med (2002) 0.77
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents. Medchemcomm (2013) 0.77
Kidney α-intercalated cells and lipocalin 2: defending the urinary tract. J Clin Invest (2014) 0.76
Increased Nitric Oxide Production Prevents Airway Hyperresponsiveness in Caveolin-1 Deficient Mice Following Endotoxin Exposure. J Allergy Ther (2012) 0.76
Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice. J Allergy Clin Immunol (2012) 0.75
How mast cells make decisions. J Clin Invest (2016) 0.75
Mast cell desensitization inhibits calcium flux and aberrantly remodels actin. J Clin Invest (2016) 0.75
Author reply--an unusual case of cardiac amyloidosis. J Gen Intern Med (2007) 0.75
An unusual case of cardiac amyloidosis. J Gen Intern Med (2007) 0.75
Cases from the Osler Medical Service at Johns Hopkins University. Antiglomerular basement membrane disease. Am J Med (2003) 0.75
Cases from the Osler Medical Service at Johns Hopkins University. Wegener's granulomatosis. Am J Med (2003) 0.75
Cases from the Osler Medical Service at Johns Hopkins University. Am J Med (2003) 0.75
Cases from the Osler Medical Service at Johns Hopkins University. Am J Med (2003) 0.75
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest (2017) 0.75
Cases from the Osler Medical Service at Johns Hopkins University. Am J Med (2003) 0.75
[Quantitative assessment of left ventricular systolic dyssynchrony in relation to systolic function by real-time three-dimensional echocardiography-derived regional systolic dyssynchrony index in chronic heart failure patients]. Nan Fang Yi Ke Da Xue Xue Bao (2012) 0.75